Clinical Trial

Valved Graft PMCF Study

Recruiting
View on ClinicalTrials.gov →
Summary
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-02-10; most recent amendment 2026-04-07.
Status change: Not Yet Recruiting → Recruiting 2021-07-29
Trial Details
NCT Number NCT04754217
Lead Sponsor Abbott Medical Devices
Conditions Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Enrollment 260 participants
Start Date 2021-07-13
Primary Completion 2029-07 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2026-04-13